Because OPN has been detected in considerably high quantities in RA and OA patients and in vitro analyses and experimental models have proposed it as an effector protein of joint damage, in this review, we propose that OPN could be considered a common denominator of the immunopathology of these rheumatic diseases. This evidence concerns the gene SPP1 and rheumatic disorder.